Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

An 86-year-old man had a rare tongue melanoma but refused treatment, showing the need for early cancer detection and treatment.

A new tool allows easier long-term imaging of live skin cells, helping study diseases like skin cancer.

PRP injections are safe for hair loss treatment, but monitoring and sun protection are advised.

Wnt signaling is crucial for skin wound healing and reducing scars.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Understanding EGFR roles could lead to new hair loss treatments.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Apoptosis is crucial for healthy skin and treating skin diseases.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Erlotinib can cause hair loss and texture changes.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Erlotinib can cause persistent excessive hair growth.

Ginseng can cause skin eruptions in some people.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Erlotinib can cause hair loss as a side effect.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Advancements in dermatology are improving diagnosis, treatment options, and patient care.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.